European equities traded in the US as American depositary receipts were down late Tuesday morning, declining 0.2% to 1,586.32 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company Ericsson (ERIC) and pharmaceutical company Sanofi, which rose 1.3% and 0.6% respectively. They were followed by petroleum refiner Equinor (EQNR) and accommodations booking site trivago (TRVG), which were up 0.4% and 0.3% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which fell 7% and 6% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Ascendis Pharma (ASND), which were down 3.5% and 3.3% respectively.

From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and cruise line operator Carnival (CUK), which advanced 4.3% and 2.4% respectively. They were followed by educational publisher Pearson (PSO) and lender HSBC (HSBC), which increased 1.6% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which tumbled 22% and 10% respectively. They were followed by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which dropped more than 4% and 3% respectively.